IBS Chat

About the Book

IBS Chat: Real Life Stories and Solutions is a compilation of the best postings by members of the Internet-based Irritable Bowel Syndrome Self Help and Support Group. In an organized and easily accessible manner, authors Jeffrey Roberts, a lifelong IBS sufferer, and Barbara Bradley Bolen, PhD, present practical strategies for managing symptoms, information about a wide variety of treatment options, and insight into the effect that this devastating disorder can have on a person's life. Most importantly, you'll find reassurance that IBS is a treatable medical condition.

"Jeffrey Roberts and Dr. Barbara Bolen have done a remarkable job of compiling key comments, from all over the world, about IBS and the functional GI disorders. The information is well-organized, readable, and informative. I believe this book also helps to provide emotional support: the reader learns that he or she is "not alone" during those times when the symptoms are distressing or difficult to manage."
-Douglas A. Drossman, MD
Medical Director, UNC Center for Functional GI and Motility Disorders

"This book provides very valuable insights from IBS sufferers that would be informative to other affected individuals and health care providers. I was most impressed by the communication between participants, who ranged from those wanting a better understanding about IBS and their symptoms, to those from very knowledgeable individuals. This level of social support between IBS sufferers can be very helpful in managing the symptoms of IBS."
-Lin Chang, MD
UCLA Center for Neurovisceral Sciences and Women's Health
CURE: Digestive Diseases Research Center
UCLA Department of Medicine - Division of Digestive Diseases

About the Author

Jeffrey D. Roberts, MS, is the founder and president of the Irritable Bowel Syndrome Self Help and Support Group, the world?s premier online community for people with IBS. He is known world wide as a patient advocate, working closely with sufferers, health care professionals, the media, regulatory agencies and pharmaceutical companies.